ARCHIVES

DCT Board Approves Recompetition Of Drug Development Contracts

This article is from The Cancer Letter archive.

Vol. 19 No. 26 | June 25, 1993

Download PDF Visit The Full Archive

Related Articles

Researchers Identify Subtype Demonstrating Angiogenesis

February 24, 2012

NCI Grant Boosts UCLA Bladder Cancer Project

October 25, 2002

NCI Clarifies IRPG Application Receipt, Funding Policies

September 3, 1993

“Unfortunate Result Of Burzynski’s Practice Over Two Decades: Thousands Of Patients, Not Enough Data” To Determine Safety, Efficacy, FDA Says

September 25, 1998

Tobacco Regulation: ACS Advocates Giving FDA Full Authority Over Tobacco

January 23, 1998

Vermont Cancer Center’s NCI Core Grant Renewed.

May 11, 2001